/
Stock
/
/
APIChangelogInfo

IONIS PHARMACEUTICALS

Trade IONS
IONS Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-05-01
2025-05-02
HAYDEN MICHAEL
P - Purchase
Common Stock
15,000
$32.00
480K
1
$5.66B
2025-04-16
2025-04-17
BAROLDI JOSEPH
EVP, Chief Business Officer
S - Sale
Common Stock
-3,928
$28.00
-110K
1
$5.66B
2025-04-16
2025-04-17
JENNE KYLE
EVP, Chf GL Pdt Str Ofcr
S - Sale
Common Stock
-3,016
$28.00
-84,448
1
$5.66B
2025-04-16
2025-04-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
S - Sale
Common Stock
-680
$28.00
-19,040
1
$5.66B
2025-04-15
2025-04-17
BAROLDI JOSEPH
EVP, Chief Business Officer
M - Exercise
Restricted Stock Unit
-10,837
$0.00
1
$5.66B
2025-04-15
2025-04-17
BAROLDI JOSEPH
EVP, Chief Business Officer
M - Exercise
Common Stock
10,837
$0.00
1
$5.66B
2025-04-15
2025-04-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
M - Exercise
Common Stock
1,875
$0.00
1
$5.66B
2025-04-15
2025-04-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
M - Exercise
Restricted Stock Unit
-1,875
$0.00
1
$5.66B
2025-04-15
2025-04-17
JENNE KYLE
EVP, Chf GL Pdt Str Ofcr
M - Exercise
Restricted Stock Unit
-12,226
$0.00
1
$5.66B
2025-04-15
2025-04-17
JENNE KYLE
EVP, Chf GL Pdt Str Ofcr
M - Exercise
Common Stock
12,226
$0.00
1
$5.66B
2025-03-11
2025-03-13
MONIA BRETT
Chief Executive Officer
S - Sale
Common Stock
-140
$32.00
-4,480
1
$5.66B
2025-02-28
2025-03-04
BENNETT FRANK
EVP, Chief Scientific Officer
J - Other
Common Stock
320
$28.00
8,960
1
$5.66B
2025-02-28
2025-03-04
BIRCHLER BRIAN
EVP, Corp and Development Ops
J - Other
Common Stock
414
$28.00
11,592
1
$5.66B
2025-02-28
2025-03-04
SWAYZE ERIC
EVP Research
J - Other
Common Stock
415
$28.00
11,620
1
$5.66B
2025-02-28
2025-03-04
GEARY RICHARD
EVP, Chief Development Officer
J - Other
Common Stock
415
$28.00
11,620
1
$5.66B
2025-02-28
2025-03-04
O'NEIL PATRICK
EVP CLO & General Counsel
J - Other
Common Stock
554
$28.00
15,512
1
$5.66B
2025-02-28
2025-03-04
MONIA BRETT
Chief Executive Officer
J - Other
Common Stock
437
$28.00
12,236
1
$5.66B
2025-02-20
2025-02-24
O'NEIL PATRICK
EVP CLO & General Counsel
S - Sale
Common Stock
-1,207
$32.00
-38,624
1
$5.66B
2025-02-04
2025-02-06
O'NEIL PATRICK
EVP CLO & General Counsel
S - Sale
Common Stock
-6,165
$32.00
-197K
1
$5.66B
2025-02-04
2025-02-06
MONIA BRETT
Chief Executive Officer
S - Sale
Common Stock
-38,843
$32.00
-1.24M
1
$5.66B
2025-02-04
2025-02-04
O'NEIL PATRICK
EVP CLO & General Counsel
S - Sale
-7,372
$32.00
-236K
1
$5.66B
2025-02-04
2025-02-04
O'NEIL PATRICK
EVP CLO & General Counsel
S - Sale
-7,372
$32.00
-236K
1
$5.66B
2025-02-04
2025-02-04
MONIA BRETT
Chief Executive Officer
S - Sale
-40,003
$32.00
-1.28M
1
$5.66B
2025-01-31
2025-02-03
MONIA BRETT
Chief Executive Officer
S - Sale
Common Stock
-13,242
$32.00
-424K
1
$5.66B
2025-01-31
2025-02-03
HOUGEN ELIZABETH
EVP, Finance & CFO
S - Sale
Common Stock
-1,523
$32.00
-48,736
1
$5.66B
2025-01-31
2025-02-03
GEARY RICHARD
EVP, Chief Development Officer
S - Sale
Common Stock
-1,406
$32.00
-44,992
1
$5.66B
2025-01-31
2025-02-03
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
S - Sale
Common Stock
-1,484
$32.00
-47,488
1
$5.66B
2025-01-31
2025-02-03
BENNETT FRANK
EVP, Chief Scientific Officer
S - Sale
Common Stock
-1,327
$32.00
-42,464
1
$5.66B
2025-01-31
2025-02-03
O'NEIL PATRICK
EVP CLO & General Counsel
S - Sale
Common Stock
-1,406
$32.00
-44,992
1
$5.66B
2025-01-31
2025-02-03
SWAYZE ERIC
EVP Research
S - Sale
Common Stock
-1,367
$32.00
-43,744
1
$5.66B
2025-01-30
2025-02-03
MONIA BRETT
Chief Executive Officer
A - Grant
Common Stock
25,372
$0.00
1
$5.66B
2025-01-30
2025-02-03
HOUGEN ELIZABETH
EVP, Finance & CFO
A - Grant
Common Stock
4,138
$0.00
1
$5.66B
2025-01-30
2025-02-03
O'NEIL PATRICK
EVP CLO & General Counsel
A - Grant
Common Stock
3,820
$0.00
1
$5.66B
2025-01-30
2025-02-03
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
A - Grant
Common Stock
4,032
$0.00
1
$5.66B
2025-01-30
2025-02-03
BENNETT FRANK
EVP, Chief Scientific Officer
A - Grant
Common Stock
3,607
$0.00
1
$5.66B
2025-01-30
2025-02-03
SWAYZE ERIC
EVP Research
A - Grant
Common Stock
3,714
$0.00
1
$5.66B
2025-01-30
2025-02-03
GEARY RICHARD
EVP, Chief Development Officer
A - Grant
Common Stock
3,820
$0.00
1
$5.66B
2025-01-31
2025-01-31
HOUGEN ELIZABETH
EVP, Finance & CFO
S - Sale
-2,069
$35.00
-72,415
1
$5.66B
2025-01-31
2025-01-31
GEARY RICHARD
EVP, Chief Development Officer
S - Sale
-1,910
$35.00
-66,850
1
$5.66B
2025-01-31
2025-01-31
O'NEIL PATRICK
EVP CLO & General Counsel
S - Sale
-1,910
$35.00
-66,850
1
$5.66B
2025-01-31
2025-01-31
SWAYZE ERIC
EVP Research
S - Sale
-1,857
$35.00
-64,995
1
$5.66B
2025-01-31
2025-01-31
BENNETT FRANK
EVP, Chief Scientific Officer
S - Sale
-1,803
$35.00
-63,105
1
$5.66B
2025-01-31
2025-01-31
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
S - Sale
-1,700
$33.00
-56,100
1
$5.66B
2025-01-16
2025-01-17
GEARY RICHARD
EVP, Chief Development Officer
S - Sale
Common Stock
-7,072
$33.00
-233K
1
$5.66B
2025-01-16
2025-01-17
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
S - Sale
Common Stock
-6,523
$33.00
-215K
1
$5.66B
2025-01-16
2025-01-17
O'NEIL PATRICK
EVP CLO & General Counsel
S - Sale
Common Stock
-7,360
$33.00
-243K
1
$5.66B
2025-01-16
2025-01-17
HOUGEN ELIZABETH
EVP, Finance & CFO
S - Sale
Common Stock
-8,870
$33.00
-293K
1
$5.66B
2025-01-16
2025-01-17
DEVERS SHANNON
EVP, Chief Human Resources Ofc
S - Sale
Common Stock
-4,267
$33.00
-141K
1
$5.66B
2025-01-16
2025-01-17
BENNETT FRANK
EVP, Chief Scientific Officer
S - Sale
Common Stock
-6,752
$33.00
-223K
1
$5.66B
2025-01-16
2025-01-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
S - Sale
Common Stock
-5,400
$33.00
-178K
1
$5.66B
2025-01-16
2025-01-17
BAROLDI JOSEPH
EVP, Chief Business Officer
S - Sale
Common Stock
-4,430
$33.00
-146K
2
$5.66B
2025-01-16
2025-01-17
SWAYZE ERIC
EVP Research
S - Sale
Common Stock
-7,176
$33.00
-237K
2
$5.66B
2025-01-16
2025-01-17
MONIA BRETT
Chief Executive Officer
S - Sale
Common Stock
-33,445
$33.00
-1.10M
1
$5.66B
2025-01-15
2025-01-17
GEARY RICHARD
EVP, Chief Development Officer
M - Exercise
Common Stock
18,901
$0.00
1
$5.66B
2025-01-15
2025-01-17
O'NEIL PATRICK
EVP CLO & General Counsel
M - Exercise
Restricted Stock Unit
-19,690
$0.00
1
$5.66B
2025-01-15
2025-01-17
DEVERS SHANNON
EVP, Chief Human Resources Ofc
M - Exercise
Common Stock
12,295
$0.00
1
$5.66B
2025-01-15
2025-01-17
HOUGEN ELIZABETH
EVP, Finance & CFO
M - Exercise
Restricted Stock Unit
-23,887
$0.00
1
$5.66B
2025-01-15
2025-01-17
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
M - Exercise
Restricted Stock Unit
-17,372
$0.00
1
$5.66B
2025-01-15
2025-01-17
JENNE KYLE
EVP, Chf GL Pdt Str Ofcr
A - Grant
Restricted Stock Unit
28,050
$0.00
1
$5.66B
2025-01-15
2025-01-17
SWAYZE ERIC
EVP Research
M - Exercise
Restricted Stock Unit
-19,160
$0.00
2
$5.66B
2025-01-15
2025-01-17
MONIA BRETT
Chief Executive Officer
M - Exercise
Common Stock
73,448
$0.00
1
$5.66B
2025-01-15
2025-01-17
SWAYZE ERIC
EVP Research
M - Exercise
Common Stock
19,160
$0.00
2
$5.66B
2025-01-15
2025-01-17
HOUGEN ELIZABETH
EVP, Finance & CFO
M - Exercise
Common Stock
23,887
$0.00
1
$5.66B
2025-01-15
2025-01-17
GEARY RICHARD
EVP, Chief Development Officer
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
MONIA BRETT
Chief Executive Officer
M - Exercise
Restricted Stock Unit
-73,448
$0.00
1
$5.66B
2025-01-15
2025-01-17
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
M - Exercise
Common Stock
17,372
$0.00
1
$5.66B
2025-01-15
2025-01-17
DEVERS SHANNON
EVP, Chief Human Resources Ofc
M - Exercise
Restricted Stock Unit
-12,295
$0.00
1
$5.66B
2025-01-15
2025-01-17
BAROLDI JOSEPH
EVP, Chief Business Officer
M - Exercise
Restricted Stock Unit
-11,247
$0.00
2
$5.66B
2025-01-15
2025-01-17
BENNETT FRANK
EVP, Chief Scientific Officer
M - Exercise
Common Stock
18,011
$0.00
1
$5.66B
2025-01-15
2025-01-17
GEARY RICHARD
EVP, Chief Development Officer
M - Exercise
Restricted Stock Unit
-18,901
$0.00
1
$5.66B
2025-01-15
2025-01-17
DEVERS SHANNON
EVP, Chief Human Resources Ofc
A - Grant
Restricted Stock Unit
33,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
DEVERS SHANNON
EVP, Chief Human Resources Ofc
A - Grant
Restricted Stock Unit
33,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
SWAYZE ERIC
EVP Research
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
A - Grant
Restricted Stock Unit
33,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
DEVERS SHANNON
EVP, Chief Human Resources Ofc
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
A - Grant
Restricted Stock Unit
33,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
DEVERS SHANNON
EVP, Chief Human Resources Ofc
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
BAROLDI JOSEPH
EVP, Chief Business Officer
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
BENNETT FRANK
EVP, Chief Scientific Officer
A - Grant
Restricted Stock Unit
33,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
BAROLDI JOSEPH
EVP, Chief Business Officer
A - Grant
Restricted Stock Unit
36,750
$0.00
2
$5.66B
2025-01-15
2025-01-17
GEARY RICHARD
EVP, Chief Development Officer
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
BAROLDI JOSEPH
EVP, Chief Business Officer
A - Grant
Restricted Stock Unit
36,750
$0.00
2
$5.66B
2025-01-15
2025-01-17
GEARY RICHARD
EVP, Chief Development Officer
A - Grant
Restricted Stock Unit
33,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
BENNETT FRANK
EVP, Chief Scientific Officer
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
BENNETT FRANK
EVP, Chief Scientific Officer
A - Grant
Restricted Stock Unit
33,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
A - Grant
Restricted Stock Unit
33,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
O'NEIL PATRICK
EVP CLO & General Counsel
A - Grant
Restricted Stock Unit
33,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
M - Exercise
Common Stock
17,372
$0.00
1
$5.66B
2025-01-15
2025-01-17
BAROLDI JOSEPH
EVP, Chief Business Officer
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
YANG MICHAEL
M - Exercise
Restricted Stock Unit
-1,931
$0.00
1
$5.66B
2025-01-15
2025-01-17
YANG MICHAEL
M - Exercise
Common Stock
1,931
$0.00
1
$5.66B
2025-01-15
2025-01-17
SWAYZE ERIC
EVP Research
A - Grant
Restricted Stock Unit
33,245
$0.00
2
$5.66B
2025-01-15
2025-01-17
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
M - Exercise
Common Stock
17,372
$0.00
1
$5.66B
2025-01-15
2025-01-17
SWAYZE ERIC
EVP Research
M - Exercise
Common Stock
19,160
$0.00
2
$5.66B
2025-01-15
2025-01-17
O'NEIL PATRICK
EVP CLO & General Counsel
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
BENNETT FRANK
EVP, Chief Scientific Officer
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
SWAYZE ERIC
EVP Research
M - Exercise
Restricted Stock Unit
-19,160
$0.00
2
$5.66B
2025-01-15
2025-01-17
HOUGEN ELIZABETH
EVP, Finance & CFO
A - Grant
Restricted Stock Unit
46,500
$0.00
1
$5.66B
2025-01-15
2025-01-17
MONIA BRETT
Chief Executive Officer
A - Grant
Performance Restricted Stock Units
170K
$0.00
1
$5.66B
2025-01-15
2025-01-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
JENNE KYLE
EVP, Chf GL Pdt Str Ofcr
A - Grant
Restricted Stock Unit
28,050
$0.00
1
$5.66B
2025-01-15
2025-01-17
O'NEIL PATRICK
EVP CLO & General Counsel
M - Exercise
Common Stock
19,690
$0.00
1
$5.66B
2025-01-15
2025-01-17
SWAYZE ERIC
EVP Research
A - Grant
Restricted Stock Unit
33,245
$0.00
2
$5.66B
2025-01-15
2025-01-17
BENNETT FRANK
EVP, Chief Scientific Officer
M - Exercise
Restricted Stock Unit
-18,011
$0.00
1
$5.66B
2025-01-15
2025-01-17
BAROLDI JOSEPH
EVP, Chief Business Officer
M - Exercise
Common Stock
11,247
$0.00
2
$5.66B
2025-01-15
2025-01-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
M - Exercise
Restricted Stock Unit
-14,283
$0.00
1
$5.66B
2025-01-15
2025-01-17
HOUGEN ELIZABETH
EVP, Finance & CFO
A - Grant
Performance Restricted Stock Units
31,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
GEARY RICHARD
EVP, Chief Development Officer
A - Grant
Restricted Stock Unit
33,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
MONIA BRETT
Chief Executive Officer
M - Exercise
Restricted Stock Unit
-73,448
$0.00
1
$5.66B
2025-01-15
2025-01-17
O'NEIL PATRICK
EVP CLO & General Counsel
M - Exercise
Restricted Stock Unit
-19,690
$0.00
1
$5.66B
2025-01-15
2025-01-17
JENNE KYLE
EVP, Chf GL Pdt Str Ofcr
A - Grant
Performance Restricted Stock Units
18,700
$0.00
1
$5.66B
2025-01-15
2025-01-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
M - Exercise
Common Stock
14,283
$0.00
1
$5.66B
2025-01-15
2025-01-17
DEVERS SHANNON
EVP, Chief Human Resources Ofc
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
O'NEIL PATRICK
EVP CLO & General Counsel
M - Exercise
Common Stock
19,690
$0.00
1
$5.66B
2025-01-15
2025-01-17
JENNE KYLE
EVP, Chf GL Pdt Str Ofcr
A - Grant
Performance Restricted Stock Units
18,700
$0.00
1
$5.66B
2025-01-15
2025-01-17
HOUGEN ELIZABETH
EVP, Finance & CFO
A - Grant
Restricted Stock Unit
46,500
$0.00
1
$5.66B
2025-01-15
2025-01-17
MONIA BRETT
Chief Executive Officer
M - Exercise
Restricted Stock Unit
-73,448
$0.00
1
$5.66B
2025-01-15
2025-01-17
GEARY RICHARD
EVP, Chief Development Officer
A - Grant
Restricted Stock Unit
33,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
MONIA BRETT
Chief Executive Officer
M - Exercise
Common Stock
73,448
$0.00
1
$5.66B
2025-01-15
2025-01-17
HOUGEN ELIZABETH
EVP, Finance & CFO
M - Exercise
Common Stock
23,887
$0.00
1
$5.66B
2025-01-15
2025-01-17
MONIA BRETT
Chief Executive Officer
A - Grant
Restricted Stock Unit
129K
$0.00
1
$5.66B
2025-01-15
2025-01-17
MONIA BRETT
Chief Executive Officer
A - Grant
Performance Restricted Stock Units
170K
$0.00
1
$5.66B
2025-01-15
2025-01-17
YANG MICHAEL
M - Exercise
Restricted Stock Unit
-1,931
$0.00
1
$5.66B
2025-01-15
2025-01-17
O'NEIL PATRICK
EVP CLO & General Counsel
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
HOUGEN ELIZABETH
EVP, Finance & CFO
M - Exercise
Common Stock
23,887
$0.00
1
$5.66B
2025-01-15
2025-01-17
DEVERS SHANNON
EVP, Chief Human Resources Ofc
A - Grant
Restricted Stock Unit
33,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
DEVERS SHANNON
EVP, Chief Human Resources Ofc
M - Exercise
Restricted Stock Unit
-12,295
$0.00
1
$5.66B
2025-01-15
2025-01-17
BENNETT FRANK
EVP, Chief Scientific Officer
A - Grant
Restricted Stock Unit
33,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
GEARY RICHARD
EVP, Chief Development Officer
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
A - Grant
Restricted Stock Unit
33,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
DEVERS SHANNON
EVP, Chief Human Resources Ofc
M - Exercise
Common Stock
12,295
$0.00
1
$5.66B
2025-01-15
2025-01-17
DEVERS SHANNON
EVP, Chief Human Resources Ofc
M - Exercise
Restricted Stock Unit
-12,295
$0.00
1
$5.66B
2025-01-15
2025-01-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
M - Exercise
Restricted Stock Unit
-14,283
$0.00
1
$5.66B
2025-01-15
2025-01-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
GEARY RICHARD
EVP, Chief Development Officer
M - Exercise
Common Stock
18,901
$0.00
1
$5.66B
2025-01-15
2025-01-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
M - Exercise
Restricted Stock Unit
-14,283
$0.00
1
$5.66B
2025-01-15
2025-01-17
BENNETT FRANK
EVP, Chief Scientific Officer
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
BENNETT FRANK
EVP, Chief Scientific Officer
M - Exercise
Common Stock
18,011
$0.00
1
$5.66B
2025-01-15
2025-01-17
BAROLDI JOSEPH
EVP, Chief Business Officer
M - Exercise
Common Stock
11,247
$0.00
2
$5.66B
2025-01-15
2025-01-17
BAROLDI JOSEPH
EVP, Chief Business Officer
A - Grant
Restricted Stock Unit
36,750
$0.00
2
$5.66B
2025-01-15
2025-01-17
BAROLDI JOSEPH
EVP, Chief Business Officer
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
BAROLDI JOSEPH
EVP, Chief Business Officer
M - Exercise
Restricted Stock Unit
-11,247
$0.00
2
$5.66B
2025-01-15
2025-01-17
SWAYZE ERIC
EVP Research
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
BAROLDI JOSEPH
EVP, Chief Business Officer
M - Exercise
Restricted Stock Unit
-11,247
$0.00
2
$5.66B
2025-01-15
2025-01-17
BENNETT FRANK
EVP, Chief Scientific Officer
M - Exercise
Restricted Stock Unit
-18,011
$0.00
1
$5.66B
2025-01-15
2025-01-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
M - Exercise
Common Stock
14,283
$0.00
1
$5.66B
2025-01-15
2025-01-17
BENNETT FRANK
EVP, Chief Scientific Officer
M - Exercise
Restricted Stock Unit
-18,011
$0.00
1
$5.66B
2025-01-15
2025-01-17
BENNETT FRANK
EVP, Chief Scientific Officer
M - Exercise
Common Stock
18,011
$0.00
1
$5.66B
2025-01-15
2025-01-17
BAROLDI JOSEPH
EVP, Chief Business Officer
M - Exercise
Common Stock
11,247
$0.00
2
$5.66B
2025-01-15
2025-01-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
M - Exercise
Common Stock
14,283
$0.00
1
$5.66B
2025-01-15
2025-01-17
SWAYZE ERIC
EVP Research
A - Grant
Restricted Stock Unit
33,245
$0.00
2
$5.66B
2025-01-15
2025-01-17
HOUGEN ELIZABETH
EVP, Finance & CFO
A - Grant
Performance Restricted Stock Units
31,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
GEARY RICHARD
EVP, Chief Development Officer
M - Exercise
Restricted Stock Unit
-18,901
$0.00
1
$5.66B
2025-01-15
2025-01-17
HOUGEN ELIZABETH
EVP, Finance & CFO
M - Exercise
Restricted Stock Unit
-23,887
$0.00
1
$5.66B
2025-01-15
2025-01-17
HOUGEN ELIZABETH
EVP, Finance & CFO
M - Exercise
Restricted Stock Unit
-23,887
$0.00
1
$5.66B
2025-01-15
2025-01-17
GEARY RICHARD
EVP, Chief Development Officer
M - Exercise
Restricted Stock Unit
-18,901
$0.00
1
$5.66B
2025-01-15
2025-01-17
SWAYZE ERIC
EVP Research
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
A - Grant
Restricted Stock Unit
33,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
O'NEIL PATRICK
EVP CLO & General Counsel
A - Grant
Restricted Stock Unit
33,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
MONIA BRETT
Chief Executive Officer
A - Grant
Restricted Stock Unit
129K
$0.00
1
$5.66B
2025-01-15
2025-01-17
GEARY RICHARD
EVP, Chief Development Officer
M - Exercise
Common Stock
18,901
$0.00
1
$5.66B
2025-01-15
2025-01-17
MONIA BRETT
Chief Executive Officer
A - Grant
Performance Restricted Stock Units
170K
$0.00
1
$5.66B
2025-01-15
2025-01-17
DEVERS SHANNON
EVP, Chief Human Resources Ofc
M - Exercise
Common Stock
12,295
$0.00
1
$5.66B
2025-01-15
2025-01-17
JENNE KYLE
EVP, Chf GL Pdt Str Ofcr
A - Grant
Restricted Stock Unit
28,050
$0.00
1
$5.66B
2025-01-15
2025-01-17
O'NEIL PATRICK
EVP CLO & General Counsel
M - Exercise
Common Stock
19,690
$0.00
1
$5.66B
2025-01-15
2025-01-17
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
M - Exercise
Restricted Stock Unit
-17,372
$0.00
1
$5.66B
2025-01-15
2025-01-17
MONIA BRETT
Chief Executive Officer
A - Grant
Restricted Stock Unit
129K
$0.00
1
$5.66B
2025-01-15
2025-01-17
SWAYZE ERIC
EVP Research
M - Exercise
Restricted Stock Unit
-19,160
$0.00
2
$5.66B
2025-01-15
2025-01-17
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
M - Exercise
Restricted Stock Unit
-17,372
$0.00
1
$5.66B
2025-01-15
2025-01-17
MONIA BRETT
Chief Executive Officer
M - Exercise
Common Stock
73,448
$0.00
1
$5.66B
2025-01-15
2025-01-17
O'NEIL PATRICK
EVP CLO & General Counsel
M - Exercise
Restricted Stock Unit
-19,690
$0.00
1
$5.66B
2025-01-15
2025-01-17
JENNE KYLE
EVP, Chf GL Pdt Str Ofcr
A - Grant
Performance Restricted Stock Units
18,700
$0.00
1
$5.66B
2025-01-15
2025-01-17
HOUGEN ELIZABETH
EVP, Finance & CFO
A - Grant
Restricted Stock Unit
46,500
$0.00
1
$5.66B
2025-01-15
2025-01-17
O'NEIL PATRICK
EVP CLO & General Counsel
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
A - Grant
Performance Restricted Stock Units
22,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
HOUGEN ELIZABETH
EVP, Finance & CFO
A - Grant
Performance Restricted Stock Units
31,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
YANG MICHAEL
M - Exercise
Restricted Stock Unit
-1,931
$0.00
1
$5.66B
2025-01-15
2025-01-17
YANG MICHAEL
M - Exercise
Common Stock
1,931
$0.00
1
$5.66B
2025-01-15
2025-01-17
SWAYZE ERIC
EVP Research
M - Exercise
Common Stock
19,160
$0.00
2
$5.66B
2025-01-15
2025-01-17
O'NEIL PATRICK
EVP CLO & General Counsel
A - Grant
Restricted Stock Unit
33,000
$0.00
1
$5.66B
2025-01-15
2025-01-17
YANG MICHAEL
M - Exercise
Common Stock
1,931
$0.00
1
$5.66B
2025-01-15
2025-01-17
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
A - Grant
Restricted Stock Unit
33,000
$0.00
1
$5.66B
2025-01-16
2025-01-16
SWAYZE ERIC
EVP Research
S - Sale
-7,154
$33.00
-236K
1
$5.66B
2025-01-16
2025-01-16
BAROLDI JOSEPH
EVP, Chief Business Officer
S - Sale
-3,401
$33.00
-112K
1
$5.66B
2025-01-02
2025-01-06
GEARY RICHARD
EVP, Chief Development Officer
A - Grant
Non-Qualified Stock Option (right to buy)
22,000
$0.00
1
$5.66B
2025-01-02
2025-01-06
BAROLDI JOSEPH
EVP, Chief Business Officer
A - Grant
Non-Qualified Stock Option (right to buy)
24,500
$0.00
2
$5.66B
2025-01-02
2025-01-06
O'NEIL PATRICK
EVP CLO & General Counsel
A - Grant
Non-Qualified Stock Option (right to buy)
22,000
$0.00
1
$5.66B
2025-01-02
2025-01-06
SWAYZE ERIC
EVP Research
A - Grant
Non-Qualified Stock Option (right to buy)
22,163
$0.00
2
$5.66B
2025-01-02
2025-01-06
HOUGEN ELIZABETH
EVP, Finance & CFO
A - Grant
Non-Qualified Stock Option (right to buy)
31,000
$0.00
1
$5.66B
2025-01-02
2025-01-06
MONIA BRETT
Chief Executive Officer
A - Grant
Non-Qualified Stock Option (right to buy)
86,263
$0.00
1
$5.66B
2025-01-02
2025-01-06
JENNE KYLE
EVP, Chf GL Pdt Str Ofcr
A - Grant
Non-Qualified Stock Option (right to buy)
18,700
$0.00
1
$5.66B
2025-01-02
2025-01-06
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
A - Grant
Non-Qualified Stock Option (right to buy)
22,000
$0.00
1
$5.66B
2025-01-02
2025-01-06
DEVERS SHANNON
EVP, Chief Human Resources Ofc
A - Grant
Non-Qualified Stock Option (right to buy)
22,000
$0.00
1
$5.66B
2025-01-02
2025-01-06
BIRCHLER BRIAN
EVP, Corp and Development Ops
A - Grant
Non-Qualified Stock Option (right to buy)
22,000
$0.00
1
$5.66B
2025-01-02
2025-01-06
BENNETT FRANK
EVP, Chief Scientific Officer
A - Grant
Non-Qualified Stock Option (right to buy)
22,000
$0.00
1
$5.66B
2024-12-23
2024-12-26
HAYDEN MICHAEL
P - Purchase
Common Stock
5,000
$36.00
180K
2
$5.66B
2024-11-12
2024-11-14
MONIA BRETT
Chief Executive Officer
S - Sale
Common Stock
-6,630
$38.00
-252K
1
$5.66B
2024-11-12
2024-11-14
LOSCALZO JOSEPH
S - Sale
Common Stock
-13,508
$38.00
-513K
1
$5.66B
2024-11-12
2024-11-14
SWAYZE ERIC
EVP Research
S - Sale
Common Stock
-1,194
$38.00
-45,372
1
$5.66B
2024-11-12
2024-11-12
MONIA BRETT
Chief Executive Officer
S - Sale
-6,629
$39.00
-259K
1
$5.66B
2024-10-16
2024-10-17
SWAYZE ERIC
EVP Research
S - Sale
Common Stock
-53
$38.00
-2,014
1
$5.66B
2024-10-15
2024-10-17
DEVERS SHANNON
EVP, Chief Human Resources Ofc
A - Grant
Restricted Stock Unit
11,280
$0.00
1
$5.66B
2024-10-15
2024-10-17
SWAYZE ERIC
EVP Research
M - Exercise
Common Stock
125
$0.00
1
$5.66B
2024-10-15
2024-10-17
SWAYZE ERIC
EVP Research
M - Exercise
Restricted Stock Unit
-125
$0.00
1
$5.66B
2024-09-29
2024-10-01
DEVERS SHANNON
EVP, Chief Human Resourses Ofc
A - Grant
Non-Qualified Stock Option (right to buy)
15,040
$0.00
1
$5.66B
2024-02-02
2024-09-05
MONIA BRETT
Chief Executive Officer
S - Sale
Common Stock
-23,907
$49.00
-1.17M
1
$5.66B
2024-08-30
2024-09-04
BENNETT FRANK
EVP, Chief Scientific Officer
J - Other
Common Stock
177
$39.00
6,903
1
$5.66B
2024-08-30
2024-09-04
BIRCHLER BRIAN
EVP, Corp and Development Ops
J - Other
Common Stock
12
$39.00
468
1
$5.66B
2024-08-30
2024-09-04
MONIA BRETT
Chief Executive Officer
J - Other
Common Stock
140
$39.00
5,460
1
$5.66B
2024-08-30
2024-09-04
GEARY RICHARD
EVP, Chief Development Officer
J - Other
Common Stock
11
$39.00
429
1
$5.66B
2024-08-30
2024-09-04
SWAYZE ERIC
EVP Research
J - Other
Common Stock
11
$39.00
429
1
$5.66B
2024-08-30
2024-09-04
O'NEIL PATRICK
EVP CLO & General Counsel
J - Other
Common Stock
246
$39.00
9,594
1
$5.66B
2024-02-02
2024-09-04
SWAYZE ERIC
EVP Research
S - Sale
Common Stock
-1,940
$50.00
-97,000
1
$5.66B
2024-02-02
2024-09-04
O'NEIL PATRICK
EVP CLO & General Counsel
S - Sale
Common Stock
-1,995
$50.00
-99,750
1
$5.66B
2024-02-02
2024-09-04
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
S - Sale
Common Stock
-2,106
$50.00
-105K
1
$5.66B
2024-02-02
2024-09-04
HOUGEN ELIZABETH
EVP, Finance & CFO
S - Sale
Common Stock
-2,162
$50.00
-108K
1
$5.66B
2024-02-02
2024-09-04
MONIA BRETT
Chief Executive Officer
S - Sale
Common Stock
-23,907
$49.00
-1.17M
1
$5.66B
2024-02-02
2024-09-04
CADORET-MANIER ONAIZA
EVP,Chf GL Pdt Str & Oper Ofc
S - Sale
Common Stock
-2,162
$50.00
-108K
1
$5.66B
2024-02-02
2024-09-04
GEARY RICHARD
EVP, Chief Development Officer
S - Sale
Common Stock
-1,995
$50.00
-99,750
1
$5.66B
2024-02-02
2024-09-04
BENNETT FRANK
EVP, Chief Scientific Officer
S - Sale
Common Stock
-1,885
$50.00
-94,250
1
$5.66B
2024-02-02
2024-09-04
MONIA BRETT
Chief Executive Officer
S - Sale
-47,814
$49.00
-2.34M
2
$5.66B
2024-02-01
2024-09-04
CADORET-MANIER ONAIZA
EVP,Chf GL Pdt Str & Oper Ofc
S - Sale
-2,162
$50.00
-108K
1
$5.66B
2024-02-01
2024-09-04
BENNETT FRANK
EVP, Chief Scientific Officer
S - Sale
-1,885
$50.00
-94,250
1
$5.66B
2024-08-29
2024-09-03
GEARY RICHARD
EVP, Chief Development Officer
S - Sale
Common Stock
-331
$50.00
-16,550
1
$5.66B
2024-08-28
2024-09-03
GEARY RICHARD
EVP, Chief Development Officer
S - Sale
Common Stock
-320
$49.00
-15,680
1
$5.66B
2024-08-05
2024-08-06
GEARY RICHARD
EVP, Chief Development Officer
S - Sale
Common Stock
-2,430
$48.00
-117K
1
$5.66B
2024-08-05
2024-08-05
GEARY RICHARD
EVP, Chief Development Officer
S - Sale
-3,128
$49.00
-153K
1
$5.66B
2024-07-16
2024-07-17
KLEIN JOSEPH III
M - Exercise
Non-Qualified Stock Option (right to buy)
-12,000
$0.00
1
$5.66B
2024-07-16
2024-07-17
KLEIN JOSEPH III
M - Exercise
Common Stock
12,000
$24.00
288K
1
$5.66B
2024-07-16
2024-07-17
KLEIN JOSEPH III
S - Sale
Common Stock
-12,000
$50.00
-600K
1
$5.66B
2024-07-16
2024-07-17
DIAZ ALLENE
S - Sale
Common Stock
-1,637
$49.00
-80,213
2
$5.66B
2024-07-15
2024-07-17
BERTHELSEN SPENCER
M - Exercise
Common Stock
4,677
$0.00
1
$5.66B
2024-07-15
2024-07-17
BERTHELSEN SPENCER
M - Exercise
Restricted Stock Unit
-4,677
$0.00
1
$5.66B
2024-07-15
2024-07-17
DIAZ ALLENE
M - Exercise
Restricted Stock Unit
-4,677
$0.00
1
$5.66B
2024-07-15
2024-07-17
WENDER JOSEPH
M - Exercise
Common Stock
4,677
$0.00
1
$5.66B
2024-07-15
2024-07-17
PARSHALL LYNNE
M - Exercise
Restricted Stock Unit
-4,677
$0.00
1
$5.66B
2024-07-15
2024-07-17
WENDER JOSEPH
M - Exercise
Restricted Stock Unit
-4,677
$0.00
1
$5.66B
2024-07-15
2024-07-17
LOSCALZO JOSEPH
M - Exercise
Common Stock
4,677
$0.00
1
$5.66B
2024-07-15
2024-07-17
PARSHALL LYNNE
M - Exercise
Common Stock
4,677
$0.00
1
$5.66B
2024-07-15
2024-07-17
HERMAN JOAN
M - Exercise
Common Stock
4,677
$0.00
1
$5.66B
2024-07-15
2024-07-17
HERMAN JOAN
M - Exercise
Restricted Stock Unit
-4,677
$0.00
1
$5.66B
2024-07-15
2024-07-17
LOSCALZO JOSEPH
M - Exercise
Restricted Stock Unit
-4,677
$0.00
1
$5.66B
2024-07-15
2024-07-17
DIAZ ALLENE
M - Exercise
Common Stock
4,677
$0.00
1
$5.66B
2024-07-01
2024-07-03
HERMAN JOAN
A - Grant
Restricted Stock Unit
4,079
$0.00
1
$5.66B
2024-07-01
2024-07-03
HERMAN JOAN
A - Grant
Non-Qualified Stock Option (right to buy)
10,111
$0.00
1
$5.66B
2024-07-01
2024-07-03
HAYDEN MICHAEL
A - Grant
Restricted Stock Unit
4,079
$0.00
1
$5.66B
2024-07-01
2024-07-03
HAYDEN MICHAEL
A - Grant
Non-Qualified Stock Option (right to buy)
10,111
$0.00
1
$5.66B
2024-07-01
2024-07-03
DIAZ ALLENE
A - Grant
Restricted Stock Unit
4,079
$0.00
1
$5.66B
2024-07-01
2024-07-03
DIAZ ALLENE
A - Grant
Non-Qualified Stock Option (right to buy)
10,111
$0.00
1
$5.66B
2024-07-01
2024-07-03
BERTHELSEN SPENCER
A - Grant
Restricted Stock Unit
4,079
$0.00
1
$5.66B
2024-07-01
2024-07-03
KLEIN JOSEPH III
A - Grant
Non-Qualified Stock Option (right to buy)
10,111
$0.00
1
$5.66B
2024-07-01
2024-07-03
BERTHELSEN SPENCER
A - Grant
Non-Qualified Stock Option (right to buy)
10,111
$0.00
1
$5.66B
2024-07-01
2024-07-03
LOSCALZO JOSEPH
A - Grant
Non-Qualified Stock Option (right to buy)
10,111
$0.00
1
$5.66B
2024-07-01
2024-07-03
KLEIN JOSEPH III
A - Grant
Restricted Stock Unit
4,079
$0.00
1
$5.66B
2024-07-01
2024-07-03
YANG MICHAEL
A - Grant
Restricted Stock Unit
4,079
$0.00
1
$5.66B
2024-07-01
2024-07-03
PARSHALL LYNNE
A - Grant
Non-Qualified Stock Option (right to buy)
10,111
$0.00
1
$5.66B
2024-07-01
2024-07-03
LOSCALZO JOSEPH
A - Grant
Restricted Stock Unit
4,079
$0.00
1
$5.66B
2024-07-01
2024-07-03
YANG MICHAEL
A - Grant
Non-Qualified Stock Option (right to buy)
10,111
$0.00
1
$5.66B
2024-07-01
2024-07-03
WENDER JOSEPH
A - Grant
Restricted Stock Unit
4,079
$0.00
1
$5.66B
2024-07-01
2024-07-03
WENDER JOSEPH
A - Grant
Non-Qualified Stock Option (right to buy)
10,111
$0.00
1
$5.66B
2024-07-01
2024-07-03
PARSHALL LYNNE
A - Grant
Restricted Stock Unit
4,079
$0.00
1
$5.66B
2024-06-17
2024-06-20
BERTHELSEN SPENCER
S - Sale
Common Stock
-16,000
$40.00
-640K
1
$5.66B
2024-06-17
2024-06-20
BERTHELSEN SPENCER
M - Exercise
Common Stock
16,000
$36.00
576K
1
$5.66B
2024-06-17
2024-06-20
BERTHELSEN SPENCER
M - Exercise
Non-Qualified Stock Option (right to buy)
-16,000
$0.00
1
$5.66B
2024-05-09
2024-05-13
WENDER JOSEPH
M - Exercise
Common Stock
16,000
$36.00
576K
1
$5.66B
2024-05-09
2024-05-13
WENDER JOSEPH
M - Exercise
Non-Qualified Stock Option (right to buy)
-16,000
$0.00
1
$5.66B
2024-05-03
2024-05-07
KLEIN JOSEPH III
S - Sale
Common Stock
-6,000
$43.00
-258K
6
$5.66B
2024-04-16
2024-04-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
S - Sale
Common Stock
-905
$42.00
-38,010
1
$5.66B
2024-04-16
2024-04-17
BAROLDI JOSEPH
EVP, Chief Business Officer
S - Sale
Common Stock
-4,006
$42.00
-168K
1
$5.66B
2024-04-15
2024-04-17
BAROLDI JOSEPH
EVP, Chief Business Officer
M - Exercise
Common Stock
10,838
$0.00
1
$5.66B
2024-04-15
2024-04-17
BAROLDI JOSEPH
EVP, Chief Business Officer
M - Exercise
Restricted Stock Unit
-10,838
$0.00
1
$5.66B
2024-04-15
2024-04-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
M - Exercise
Common Stock
1,875
$0.00
1
$5.66B
2024-04-15
2024-04-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
M - Exercise
Restricted Stock Unit
-1,875
$0.00
1
$5.66B
2024-02-26
2024-03-13
JENNE KYLE
EVP, Chf GL Pdt Str Ofcr
A - Grant
Non-Qualified Stock Option (right to buy)
65,203
$0.00
1
$5.66B
2024-02-29
2024-03-04
MONIA BRETT
CEO Level 15
J - Other
Common Stock
538
$34.00
18,292
1
$5.66B
2024-02-29
2024-03-04
GEARY RICHARD
Officer Level 14
J - Other
Common Stock
604
$34.00
20,536
1
$5.66B
2024-02-29
2024-03-04
SWAYZE ERIC
Officer Level 14
J - Other
Common Stock
605
$34.00
20,570
1
$5.66B
2024-02-29
2024-03-04
BIRCHLER BRIAN
Vice President Level 14
J - Other
Common Stock
604
$34.00
20,536
1
$5.66B
2024-02-29
2024-03-04
BENNETT FRANK
Officer Level 14
J - Other
Common Stock
383
$34.00
13,022
1
$5.66B
2024-02-16
2024-02-16
MONIA BRETT
Chief Executive Officer
S - Sale
Common Stock
-387
$44.00
-17,028
1
$5.66B
2024-02-02
2024-02-02
BENNETT FRANK
EVP, Chief Scientific Officer
S - Sale
Common Stock
-1,853
$50.00
-92,650
1
$5.66B
2024-02-02
2024-02-02
MONIA BRETT
Chief Executive Officer
S - Sale
Common Stock
-23,501
$49.00
-1.15M
1
$5.66B
2024-02-02
2024-02-02
SWAYZE ERIC
EVP Research
S - Sale
Common Stock
-1,907
$50.00
-95,350
1
$5.66B
2024-02-02
2024-02-02
GEARY RICHARD
EVP, Chief Development Officer
S - Sale
Common Stock
-1,961
$50.00
-98,050
1
$5.66B
2024-02-02
2024-02-02
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
S - Sale
Common Stock
-2,071
$50.00
-104K
1
$5.66B
2024-02-02
2024-02-02
CADORET-MANIER ONAIZA
EVP, Chf GL Pdt Str & Oper Ofc
S - Sale
Common Stock
-2,125
$50.00
-106K
1
$5.66B
2024-02-02
2024-02-02
O'NEIL PATRICK
EVP CLO & General Counsel
S - Sale
Common Stock
-1,961
$50.00
-98,050
1
$5.66B
2024-02-02
2024-02-02
HOUGEN ELIZABETH
EVP, Finance & CFO
S - Sale
Common Stock
-2,125
$50.00
-106K
1
$5.66B
2024-02-01
2024-02-02
HOUGEN ELIZABETH
EVP, Finance & CFO
A - Grant
Common Stock
4,140
$0.00
1
$5.66B
2024-02-01
2024-02-02
SWAYZE ERIC
EVP Research
A - Grant
Common Stock
3,715
$0.00
1
$5.66B
2024-02-01
2024-02-02
GEARY RICHARD
EVP, Chief Development Officer
A - Grant
Common Stock
3,820
$0.00
1
$5.66B
2024-02-01
2024-02-02
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
A - Grant
Common Stock
4,033
$0.00
1
$5.66B
2024-02-01
2024-02-02
O'NEIL PATRICK
EVP CLO & General Counsel
A - Grant
Common Stock
3,820
$0.00
1
$5.66B
2024-02-01
2024-02-02
CADORET-MANIER ONAIZA
EVP, Chf GL Pdt Str & Oper Ofc
A - Grant
Common Stock
4,140
$0.00
1
$5.66B
2024-02-01
2024-02-02
BENNETT FRANK
EVP, Chief Scientific Officer
A - Grant
Common Stock
3,609
$0.00
1
$5.66B
2024-02-01
2024-02-02
MONIA BRETT
Chief Executive Officer
A - Grant
Common Stock
45,788
$0.00
2
$5.66B
2024-01-31
2024-02-02
SWAYZE ERIC
EVP Research
S - Sale
Common Stock
-10,773
$52.00
-560K
1
$5.66B
2024-01-25
2024-01-29
MONIA BRETT
Chief Executive Officer
S - Sale
Common Stock
-2,285
$52.00
-119K
1
$5.66B
2024-01-25
2024-01-29
O'NEIL PATRICK
EVP CLO & General Counsel
S - Sale
Common Stock
-6,450
$52.00
-335K
1
$5.66B
2024-01-17
2024-01-18
HOUGEN ELIZABETH
EVP, Finance & CFO
S - Sale
Common Stock
-8,683
$50.00
-434K
1
$5.66B
2024-01-17
2024-01-18
SWAYZE ERIC
EVP Research
S - Sale
Common Stock
-6,305
$50.00
-315K
2
$5.66B
2024-01-17
2024-01-18
O'NEIL PATRICK
EVP CLO & General Counsel
S - Sale
Common Stock
-7,744
$50.00
-387K
1
$5.66B
2024-01-17
2024-01-18
MONIA BRETT
Chief Executive Officer
S - Sale
Common Stock
-32,059
$50.00
-1.60M
1
$5.66B
2024-01-17
2024-01-18
CADORET-MANIER ONAIZA
EVP, Chf GL Pdt Str & Oper Ofc
S - Sale
Common Stock
-5,564
$50.00
-278K
1
$5.66B
2024-01-17
2024-01-18
BIRCHLER BRIAN
EVP, Corp and Development Ops
S - Sale
Common Stock
-4,497
$50.00
-225K
1
$5.66B
2024-01-17
2024-01-18
BENNETT FRANK
EVP, Chief Scientific Officer
S - Sale
Common Stock
-6,745
$50.00
-337K
1
$5.66B
2024-01-17
2024-01-18
BAROLDI JOSEPH
EVP, Chief Business Officer
S - Sale
Common Stock
-2,024
$50.00
-101K
2
$5.66B
2024-01-17
2024-01-18
GEARY RICHARD
EVP, Chief Development Officer
S - Sale
Common Stock
-7,338
$50.00
-367K
1
$5.66B
2024-01-17
2024-01-18
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
S - Sale
Common Stock
-5,482
$50.00
-274K
1
$5.66B
2024-01-16
2024-01-18
BAROLDI JOSEPH
EVP, Chief Business Officer
M - Exercise
Restricted Stock Unit
-5,041
$0.00
2
$5.66B
2024-01-16
2024-01-18
SWAYZE ERIC
EVP Research
M - Exercise
Common Stock
17,090
$0.00
2
$5.66B
2024-01-16
2024-01-18
SWAYZE ERIC
EVP Research
M - Exercise
Restricted Stock Unit
-17,090
$0.00
2
$5.66B
2024-01-16
2024-01-18
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
M - Exercise
Common Stock
15,162
$0.00
1
$5.66B
2024-01-16
2024-01-18
BAROLDI JOSEPH
EVP, Chief Business Officer
M - Exercise
Common Stock
5,041
$0.00
2
$5.66B
2024-01-16
2024-01-18
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
M - Exercise
Restricted Stock Unit
-15,162
$0.00
1
$5.66B
2024-01-16
2024-01-18
O'NEIL PATRICK
EVP CLO & General Counsel
M - Exercise
Common Stock
20,641
$0.00
1
$5.66B
2024-01-16
2024-01-18
O'NEIL PATRICK
EVP CLO & General Counsel
M - Exercise
Restricted Stock Unit
-20,641
$0.00
1
$5.66B
2024-01-16
2024-01-18
MONIA BRETT
Chief Executive Officer
M - Exercise
Common Stock
68,084
$0.00
1
$5.66B
2024-01-16
2024-01-18
MONIA BRETT
Chief Executive Officer
M - Exercise
Restricted Stock Unit
-68,084
$10.00
-681K
1
$5.66B
2024-01-16
2024-01-18
HOUGEN ELIZABETH
EVP, Finance & CFO
M - Exercise
Common Stock
22,487
$0.00
1
$5.66B
2024-01-16
2024-01-18
HOUGEN ELIZABETH
EVP, Finance & CFO
M - Exercise
Restricted Stock Unit
-22,487
$0.00
1
$5.66B
2024-01-16
2024-01-18
GEARY RICHARD
EVP, Chief Development Officer
M - Exercise
Common Stock
19,852
$0.00
1
$5.66B
2024-01-16
2024-01-18
GEARY RICHARD
EVP, Chief Development Officer
M - Exercise
Restricted Stock Unit
-19,852
$0.00
1
$5.66B
2024-01-16
2024-01-18
CADORET-MANIER ONAIZA
EVP, Chf GL Pdt Str & Oper Ofc
M - Exercise
Common Stock
15,062
$0.00
1
$5.66B
2024-01-16
2024-01-18
CADORET-MANIER ONAIZA
EVP, Chf GL Pdt Str & Oper Ofc
M - Exercise
Restricted Stock Unit
-15,062
$0.00
1
$5.66B
2024-01-16
2024-01-18
BIRCHLER BRIAN
EVP, Corp and Development Ops
M - Exercise
Common Stock
12,080
$0.00
1
$5.66B
2024-01-16
2024-01-18
BIRCHLER BRIAN
EVP, Corp and Development Ops
M - Exercise
Restricted Stock Unit
-12,080
$0.00
1
$5.66B
2024-01-16
2024-01-18
BENNETT FRANK
EVP, Chief Scientific Officer
M - Exercise
Common Stock
18,314
$0.00
1
$5.66B
2024-01-16
2024-01-18
BENNETT FRANK
EVP, Chief Scientific Officer
M - Exercise
Restricted Stock Unit
-18,314
$0.00
1
$5.66B
2024-01-17
2024-01-17
BAROLDI JOSEPH
EVP, Chief Business Officer
S - Sale
-1,460
$51.00
-74,460
1
$5.66B
2024-01-17
2024-01-17
O'NEIL PATRICK
EVP CLO & General Counsel
S - Sale
-7,645
$53.00
-405K
1
$5.66B
2024-01-17
2024-01-17
SWAYZE ERIC
EVP Research
S - Sale
-6,296
$5,054.00
-32M
1
$5.66B
2024-01-15
2024-01-17
O'NEIL PATRICK
EVP CLO & General Counsel
A - Grant
Performance Restricted Stock Units
17,000
$0.00
1
$5.66B
2024-01-15
2024-01-17
MONIA BRETT
Chief Executive Officer
A - Grant
Restricted Stock Unit
87,435
$0.00
1
$5.66B
2024-01-15
2024-01-17
SWAYZE ERIC
EVP Research
A - Grant
Restricted Stock Unit
20,516
$0.00
2
$5.66B
2024-01-15
2024-01-17
SWAYZE ERIC
EVP Research
A - Grant
Performance Restricted Stock Units
17,000
$0.00
1
$5.66B
2024-01-15
2024-01-17
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
A - Grant
Restricted Stock Unit
20,400
$0.00
1
$5.66B
2024-01-15
2024-01-17
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
A - Grant
Performance Restricted Stock Units
17,000
$0.00
1
$5.66B
2024-01-15
2024-01-17
O'NEIL PATRICK
EVP CLO & General Counsel
A - Grant
Restricted Stock Unit
20,400
$0.00
1
$5.66B
2024-01-15
2024-01-17
HOUGEN ELIZABETH
EVP, Finance & CFO
A - Grant
Restricted Stock Unit
32,400
$0.00
1
$5.66B
2024-01-15
2024-01-17
HOUGEN ELIZABETH
EVP, Finance & CFO
A - Grant
Performance Restricted Stock Units
27,000
$0.00
1
$5.66B
2024-01-15
2024-01-17
GEARY RICHARD
EVP, Chief Development Officer
A - Grant
Restricted Stock Unit
20,400
$0.00
1
$5.66B
2024-01-15
2024-01-17
GEARY RICHARD
EVP, Chief Development Officer
A - Grant
Performance Restricted Stock Units
17,000
$0.00
1
$5.66B
2024-01-15
2024-01-17
CADORET-MANIER ONAIZA
EVP, Chf GL Pdt Str & Oper Ofc
A - Grant
Restricted Stock Unit
32,400
$0.00
1
$5.66B
2024-01-15
2024-01-17
CADORET-MANIER ONAIZA
EVP, Chf GL Pdt Str & Oper Ofc
A - Grant
Performance Restricted Stock Units
27,000
$0.00
1
$5.66B
2024-01-15
2024-01-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
A - Grant
Restricted Stock Unit
20,400
$0.00
1
$5.66B
2024-01-15
2024-01-17
MONIA BRETT
Chief Executive Officer
A - Grant
Performance Restricted Stock Units
144K
$0.00
1
$5.66B
2024-01-15
2024-01-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
A - Grant
Performance Restricted Stock Units
17,000
$0.00
1
$5.66B
2024-01-15
2024-01-17
BENNETT FRANK
EVP, Chief Scientific Officer
A - Grant
Restricted Stock Unit
20,400
$0.00
1
$5.66B
2024-01-15
2024-01-17
BENNETT FRANK
EVP, Chief Scientific Officer
A - Grant
Performance Restricted Stock Units
17,000
$0.00
1
$5.66B
2024-01-15
2024-01-17
BAROLDI JOSEPH
EVP, Chief Business Officer
A - Grant
Restricted Stock Unit
24,825
$0.00
3
$5.66B
2024-01-15
2024-01-17
BAROLDI JOSEPH
EVP, Chief Business Officer
A - Grant
Performance Restricted Stock Units
17,000
$0.00
1
$5.66B
2024-01-15
2024-01-17
YANG MICHAEL
A - Grant
Restricted Stock Unit
5,791
$0.00
1
$5.66B
2024-01-12
2024-01-17
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
S - Sale
Common Stock
-8,000
$53.00
-424K
1
$5.66B
2024-01-12
2024-01-17
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
M - Exercise
Non-Qualified Stock Option (right to buy)
-8,000
$0.00
1
$5.66B
2024-01-12
2024-01-17
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
M - Exercise
Common Stock
8,000
$33.00
264K
1
$5.66B
2024-01-02
2024-01-04
SWAYZE ERIC
EVP Research
A - Grant
Non-Qualified Stock Option (right to buy)
27,354
$0.00
2
$5.66B
2024-01-02
2024-01-04
BENNETT FRANK
EVP, Chief Scientific Officer
A - Grant
Non-Qualified Stock Option (right to buy)
27,200
$0.00
1
$5.66B
2024-01-02
2024-01-04
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
A - Grant
Non-Qualified Stock Option (right to buy)
27,200
$0.00
1
$5.66B
2024-01-02
2024-01-04
O'NEIL PATRICK
EVP CLO & General Counsel
A - Grant
Non-Qualified Stock Option (right to buy)
27,200
$0.00
1
$5.66B
2024-01-02
2024-01-04
MONIA BRETT
Chief Executive Officer
A - Grant
Non-Qualified Stock Option (right to buy)
117K
$0.00
1
$5.66B
2024-01-02
2024-01-04
BAROLDI JOSEPH
EVP, Chief Business Officer
A - Grant
Non-Qualified Stock Option (right to buy)
30,700
$0.00
2
$5.66B
2024-01-02
2024-01-04
HOUGEN ELIZABETH
EVP, Finance & CFO
A - Grant
Non-Qualified Stock Option (right to buy)
43,200
$0.00
1
$5.66B
2024-01-02
2024-01-04
GEARY RICHARD
EVP, Chief Development Officer
A - Grant
Non-Qualified Stock Option (right to buy)
27,200
$0.00
1
$5.66B
2024-01-02
2024-01-04
CADORET-MANIER ONAIZA
EVP, Chf GL Pdt Str & Oper Ofc
A - Grant
Non-Qualified Stock Option (right to buy)
43,200
$0.00
1
$5.66B
2024-01-02
2024-01-04
BIRCHLER BRIAN
EVP, Corp and Development Ops
A - Grant
Non-Qualified Stock Option (right to buy)
27,200
$0.00
1
$5.66B
2023-12-28
2024-01-02
BIRCHLER BRIAN
EVP, Corp and Development Ops
M - Exercise
Common Stock
11,500
$47.00
541K
1
$5.66B
2023-12-28
2024-01-02
BIRCHLER BRIAN
EVP, Corp and Development Ops
M - Exercise
Non-Qualified Stock Option (right to buy)
-11,500
$0.00
1
$5.66B
2023-12-28
2024-01-02
HOUGEN ELIZABETH
EVP, Finance & CFO
M - Exercise
Non-Qualified Stock Option (right to buy)
-45,225
$0.00
1
$5.66B
2023-12-28
2024-01-02
HOUGEN ELIZABETH
EVP, Finance & CFO
F - Tax
Common Stock
-43,798
$51.00
-2.23M
1
$5.66B
2023-12-28
2024-01-02
SWAYZE ERIC
EVP Research
S - Sale
Common Stock
-27,100
$50.00
-1.35M
1
$5.66B
2023-12-28
2024-01-02
SWAYZE ERIC
EVP Research
M - Exercise
Common Stock
27,100
$47.00
1.27M
1
$5.66B
2023-12-28
2024-01-02
SWAYZE ERIC
EVP Research
M - Exercise
Non-Qualified Stock Option (right to buy)
-27,100
$0.00
1
$5.66B
2023-12-28
2024-01-02
BIRCHLER BRIAN
EVP, Corp and Development Ops
F - Tax
Common Stock
-11,029
$51.00
-562K
1
$5.66B
2023-12-28
2024-01-02
HOUGEN ELIZABETH
EVP, Finance & CFO
M - Exercise
Common Stock
45,225
$47.00
2.13M
1
$5.66B
2023-12-28
2023-12-28
PARSHALL LYNNE
M - Exercise
Common Stock
42,525
$47.00
2.00M
1
$5.66B
2023-12-28
2023-12-28
PARSHALL LYNNE
M - Exercise
Non-Qualified Stock Option (right to buy)
-42,525
$0.00
1
$5.66B
2023-12-28
2023-12-28
PARSHALL LYNNE
S - Sale
Common Stock
-42,525
$50.00
-2.13M
1
$5.66B
2023-12-27
2023-12-28
PARSHALL LYNNE
M - Exercise
Common Stock
50,000
$47.00
2.35M
1
$5.66B
2023-12-27
2023-12-28
PARSHALL LYNNE
M - Exercise
Non-Qualified Stock Option (right to buy)
-50,000
$0.00
1
$5.66B
2023-12-27
2023-12-28
PARSHALL LYNNE
S - Sale
Common Stock
-50,000
$50.00
-2.50M
1
$5.66B
2023-12-26
2023-12-28
O'NEIL PATRICK
EVP CLO & General Counsel
S - Sale
Common Stock
-20,825
$51.00
-1.06M
1
$5.66B
2023-12-26
2023-12-28
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
M - Exercise
Common Stock
25,000
$47.00
1.18M
1
$5.66B
2023-12-26
2023-12-28
PARSHALL LYNNE
S - Sale
Common Stock
-25,113
$51.00
-1.28M
1
$5.66B
2023-12-26
2023-12-28
O'NEIL PATRICK
EVP CLO & General Counsel
M - Exercise
Non-Qualified Stock Option (right to buy)
-20,825
$0.00
1
$5.66B
2023-12-26
2023-12-28
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
S - Sale
Common Stock
-25,000
$51.00
-1.27M
1
$5.66B
2023-12-26
2023-12-28
SCHNEIDER EUGENE
EVP, Chf Clinical Develop Ofcr
M - Exercise
Non-Qualified Stock Option (right to buy)
-25,000
$0.00
1
$5.66B
2023-12-26
2023-12-28
PARSHALL LYNNE
M - Exercise
Common Stock
25,113
$47.00
1.18M
1
$5.66B
2023-12-26
2023-12-28
PARSHALL LYNNE
M - Exercise
Non-Qualified Stock Option (right to buy)
-25,113
$0.00
1
$5.66B
2023-12-26
2023-12-28
O'NEIL PATRICK
EVP CLO & General Counsel
M - Exercise
Common Stock
20,825
$47.00
979K
1
$5.66B
2023-12-26
2023-12-27
PARSHALL LYNNE
S - Sale
-118K
$52.00
-6.12M
1
$5.66B
2023-12-21
2023-12-22
BENNETT FRANK
EVP, Chief Scientific Officer
M - Exercise
Common Stock
16,113
$47.00
757K
1
$5.66B
2023-12-21
2023-12-22
BENNETT FRANK
EVP, Chief Scientific Officer
M - Exercise
Non-Qualified Stock Option (right to buy)
-16,113
$0.00
1
$5.66B
2023-12-21
2023-12-22
GEARY RICHARD
EVP, Chief Development Officer
M - Exercise
Common Stock
4,112
$47.00
193K
1
$5.66B
2023-12-21
2023-12-22
MONIA BRETT
Chief Executive Officer
S - Sale
Common Stock
-17,500
$49.00
-858K
1
$5.66B
2023-12-21
2023-12-22
GEARY RICHARD
EVP, Chief Development Officer
M - Exercise
Non-Qualified Stock Option (right to buy)
-4,112
$0.00
1
$5.66B
2023-12-21
2023-12-22
BENNETT FRANK
EVP, Chief Scientific Officer
S - Sale
Common Stock
-16,113
$49.00
-790K
1
$5.66B
2023-12-21
2023-12-22
MONIA BRETT
Chief Executive Officer
M - Exercise
Non-Qualified Stock Option (right to buy)
-17,500
$0.00
1
$5.66B
2023-12-21
2023-12-22
MONIA BRETT
Chief Executive Officer
M - Exercise
Common Stock
17,500
$47.00
823K
1
$5.66B
2023-12-21
2023-12-22
GEARY RICHARD
EVP, Chief Development Officer
S - Sale
Common Stock
-4,112
$49.00
-201K
1
$5.66B
2023-12-20
2023-12-22
BENNETT FRANK
EVP, Chief Scientific Officer
M - Exercise
Non-Qualified Stock Option (right to buy)
-6,500
$0.00
1
$5.66B
2023-12-20
2023-12-22
MONIA BRETT
Chief Executive Officer
S - Sale
Common Stock
-6,500
$50.00
-325K
1
$5.66B
2023-12-20
2023-12-22
MONIA BRETT
Chief Executive Officer
M - Exercise
Non-Qualified Stock Option (right to buy)
-6,500
$0.00
1
$5.66B
2023-12-20
2023-12-22
GEARY RICHARD
EVP, Chief Development Officer
M - Exercise
Common Stock
6,500
$47.00
306K
1
$5.66B
2023-12-20
2023-12-22
GEARY RICHARD
EVP, Chief Development Officer
S - Sale
Common Stock
-6,500
$50.00
-325K
1
$5.66B
2023-12-20
2023-12-22
BENNETT FRANK
EVP, Chief Scientific Officer
M - Exercise
Common Stock
6,500
$47.00
306K
1
$5.66B
2023-12-20
2023-12-22
BENNETT FRANK
EVP, Chief Scientific Officer
S - Sale
Common Stock
-6,500
$50.00
-325K
1
$5.66B
2023-12-20
2023-12-22
MONIA BRETT
Chief Executive Officer
M - Exercise
Common Stock
6,500
$47.00
306K
1
$5.66B
2023-12-20
2023-12-22
GEARY RICHARD
EVP, Chief Development Officer
M - Exercise
Non-Qualified Stock Option (right to buy)
-6,500
$0.00
1
$5.66B
2023-12-14
2023-12-18
BENNETT FRANK
EVP, Chief Scientific Officer
S - Sale
Common Stock
-22,612
$50.00
-1.13M
2
$5.66B
2023-12-14
2023-12-18
YANG MICHAEL
A - Grant
Non-Qualified Stock Option (right to buy)
12,356
$0.00
1
$5.66B
2023-12-14
2023-12-18
MONIA BRETT
Chief Executive Officer
S - Sale
Common Stock
-24,000
$50.00
-1.20M
2
$5.66B
2023-12-14
2023-12-18
GEARY RICHARD
EVP, Chief Development Officer
S - Sale
Common Stock
-10,613
$50.00
-531K
2
$5.66B
2023-12-14
2023-12-18
MONIA BRETT
Chief Executive Officer
M - Exercise
Common Stock
24,000
$47.00
1.13M
2
$5.66B
2023-12-14
2023-12-18
GEARY RICHARD
EVP, Chief Development Officer
M - Exercise
Common Stock
10,613
$47.00
499K
2
$5.66B
2023-12-14
2023-12-18
MONIA BRETT
Chief Executive Officer
M - Exercise
Non-Qualified Stock Option (right to buy)
-24,000
$0.00
2
$5.66B
2023-12-14
2023-12-18
BENNETT FRANK
EVP, Chief Scientific Officer
M - Exercise
Common Stock
22,612
$47.00
1.06M
2
$5.66B
2023-12-14
2023-12-18
GEARY RICHARD
EVP, Chief Development Officer
M - Exercise
Non-Qualified Stock Option (right to buy)
-10,613
$0.00
2
$5.66B
2023-12-14
2023-12-18
BENNETT FRANK
EVP, Chief Scientific Officer
M - Exercise
Non-Qualified Stock Option (right to buy)
-22,612
$0.00
2
$5.66B
2023-12-14
2023-12-15
MONIA BRETT
Chief Executive Officer
S - Sale
-10,613
$50.00
-531K
1
$5.66B
2023-12-14
2023-12-15
GEARY RICHARD
EVP, Chief Development Officer
S - Sale
-24,000
$50.00
-1.20M
1
$5.66B
2023-12-14
2023-12-15
GEARY RICHARD
EVP, Chief Development Officer
S - Sale
-24,000
$50.00
-1.20M
1
$5.66B
2023-12-14
2023-12-15
MONIA BRETT
Chief Executive Officer
S - Sale
-10,613
$50.00
-531K
1
$5.66B
2023-11-15
2023-11-17
KLEIN JOSEPH III
S - Sale
Common Stock
-2,000
$50.00
-100K
1
$5.66B
2023-10-01
2023-11-01
BAROLDI JOSEPH
EVP, Chief Business Officer
A - Grant
Non-Qualified Stock Option (right to buy)
2,400
$0.00
1
$5.66B
2023-10-17
2023-10-18
SWAYZE ERIC
EVP Research
S - Sale
Common Stock
-52
$48.00
-2,496
1
$5.66B
2023-10-16
2023-10-18
SWAYZE ERIC
EVP Research
M - Exercise
Restricted Stock Unit
-125
$0.00
1
$5.66B
2023-10-16
2023-10-18
SWAYZE ERIC
EVP Research
M - Exercise
Common Stock
125
$0.00
1
$5.66B
2023-10-12
2023-10-16
MONIA BRETT
Chief Executive Officer
S - Sale
Common Stock
-3,770
$46.00
-173K
1
$5.66B
2023-09-28
2023-09-29
BENNETT FRANK
EVP, Chief Scientific Officer
S - Sale
Common Stock
-4,460
$47.00
-210K
1
$5.66B
2023-09-26
2023-09-28
KLEIN JOSEPH III
S - Sale
Common Stock
-2,000
$45.00
-90,000
1
$5.66B
2023-09-26
2023-09-28
PARSHALL LYNNE
S - Sale
Common Stock
-10,000
$45.00
-450K
1
$5.66B
2023-08-31
2023-09-05
BENNETT FRANK
Officer Level 14
J - Other
Common Stock
180
$31.00
5,580
1
$5.66B
2023-08-31
2023-09-05
MONIA BRETT
CEO Level 15
J - Other
Common Stock
157
$31.00
4,867
1
$5.66B
2023-08-31
2023-09-05
GEARY RICHARD
Officer Level 14
J - Other
Common Stock
1
$31.00
31
1
$5.66B
2023-08-01
2023-08-03
DIAZ ALLENE
S - Sale
Common Stock
-657
$41.00
-26,937
1
$5.66B
2023-07-18
2023-07-19
KLEIN JOSEPH III
S - Sale
Common Stock
-3,555
$42.00
-149K
1
$5.66B
2023-07-17
2023-07-19
BERTHELSEN SPENCER
M - Exercise
Common Stock
7,110
$0.00
2
$5.66B
2023-07-17
2023-07-19
BERTHELSEN SPENCER
M - Exercise
Restricted Stock Unit
-7,110
$0.00
2
$5.66B
2023-07-17
2023-07-19
KLEIN JOSEPH III
M - Exercise
Restricted Stock Unit
-7,110
$0.00
2
$5.66B
2023-07-17
2023-07-19
LOSCALZO JOSEPH
M - Exercise
Restricted Stock Unit
-7,110
$0.00
2
$5.66B
2023-07-17
2023-07-19
KLEIN JOSEPH III
M - Exercise
Common Stock
7,110
$0.00
2
$5.66B
2023-07-17
2023-07-19
WENDER JOSEPH
M - Exercise
Common Stock
7,110
$0.00
2
$5.66B
2023-07-17
2023-07-19
WENDER JOSEPH
M - Exercise
Restricted Stock Unit
-7,110
$0.00
2
$5.66B
2023-07-17
2023-07-19
PARSHALL LYNNE
M - Exercise
Common Stock
7,110
$0.00
2
$5.66B
2023-07-17
2023-07-19
PARSHALL LYNNE
M - Exercise
Restricted Stock Unit
-7,110
$0.00
2
$5.66B
2023-07-17
2023-07-19
LOSCALZO JOSEPH
M - Exercise
Common Stock
7,110
$0.00
2
$5.66B
2023-07-17
2023-07-19
HERMAN JOAN
M - Exercise
Common Stock
7,110
$0.00
2
$5.66B
2023-07-17
2023-07-19
HERMAN JOAN
M - Exercise
Restricted Stock Unit
-7,110
$0.00
2
$5.66B
2023-07-17
2023-07-19
HAYDEN MICHAEL
M - Exercise
Common Stock
7,110
$0.00
2
$5.66B
2023-07-17
2023-07-19
HAYDEN MICHAEL
M - Exercise
Restricted Stock Unit
-7,110
$0.00
2
$5.66B
2023-07-17
2023-07-19
DIAZ ALLENE
M - Exercise
Common Stock
5,333
$0.00
1
$5.66B
2023-07-17
2023-07-19
DIAZ ALLENE
M - Exercise
Restricted Stock Unit
-5,333
$0.00
1
$5.66B
2023-07-07
2023-07-11
MONIA BRETT
Chief Executive Officer
S - Sale
Common Stock
-18,650
$42.00
-783K
1
$5.66B
2023-07-03
2023-07-06
DIAZ ALLENE
A - Grant
Non-Qualified Stock Option (right to buy)
10,321
$0.00
1
$5.66B
2023-07-03
2023-07-06
BERTHELSEN SPENCER
A - Grant
Restricted Stock Unit
4,677
$0.00
1
$5.66B
2023-07-03
2023-07-06
DIAZ ALLENE
A - Grant
Restricted Stock Unit
4,677
$0.00
1
$5.66B
2023-07-03
2023-07-06
BERTHELSEN SPENCER
A - Grant
Non-Qualified Stock Option (right to buy)
10,321
$0.00
1
$5.66B
2023-07-03
2023-07-06
WENDER JOSEPH
A - Grant
Restricted Stock Unit
4,677
$0.00
1
$5.66B
2023-07-03
2023-07-06
WENDER JOSEPH
A - Grant
Non-Qualified Stock Option (right to buy)
10,321
$0.00
1
$5.66B
2023-07-03
2023-07-06
HERMAN JOAN
A - Grant
Non-Qualified Stock Option (right to buy)
10,321
$0.00
1
$5.66B
2023-07-03
2023-07-06
PARSHALL LYNNE
A - Grant
Restricted Stock Unit
4,677
$0.00
1
$5.66B
2023-07-03
2023-07-06
PARSHALL LYNNE
A - Grant
Non-Qualified Stock Option (right to buy)
10,321
$0.00
1
$5.66B
2023-07-03
2023-07-06
LOSCALZO JOSEPH
A - Grant
Restricted Stock Unit
4,677
$0.00
1
$5.66B
2023-07-03
2023-07-06
LOSCALZO JOSEPH
A - Grant
Non-Qualified Stock Option (right to buy)
10,321
$0.00
1
$5.66B
2023-07-03
2023-07-06
KLEIN JOSEPH III
A - Grant
Restricted Stock Unit
4,677
$0.00
1
$5.66B
2023-07-03
2023-07-06
KLEIN JOSEPH III
A - Grant
Non-Qualified Stock Option (right to buy)
10,321
$0.00
1
$5.66B
2023-07-03
2023-07-06
HERMAN JOAN
A - Grant
Restricted Stock Unit
4,677
$0.00
1
$5.66B
2023-07-03
2023-07-06
HAYDEN MICHAEL
A - Grant
Restricted Stock Unit
4,677
$0.00
1
$5.66B
2023-07-03
2023-07-06
HAYDEN MICHAEL
A - Grant
Non-Qualified Stock Option (right to buy)
10,321
$0.00
1
$5.66B
2023-06-20
2023-06-22
BERTHELSEN SPENCER
M - Exercise
Common Stock
11,250
$28.00
315K
1
$5.66B
2023-06-20
2023-06-22
BERTHELSEN SPENCER
M - Exercise
Non-Qualified Stock Option (right to buy)
-11,250
$0.00
1
$5.66B
2023-06-12
2023-06-14
HERMAN JOAN
M - Exercise
Restricted Stock Unit
-3,555
$0.00
1
$5.66B
2023-06-12
2023-06-14
HERMAN JOAN
M - Exercise
Common Stock
3,555
$0.00
1
$5.66B
2023-05-24
2023-05-24
O'NEIL PATRICK
EVP CLO & General Counsel
S - Sale
Common Stock
-1,527
$42.00
-64,134
1
$5.66B
2023-05-22
2023-05-24
MONIA BRETT
Chief Executive Officer
S - Sale
Common Stock
-4,931
$40.00
-197K
2
$5.66B
2023-05-22
2023-05-22
INSIGHT SECURITIES, INC.
S - Sale
-4,931
$40.00
-197K
1
$5.66B
2023-04-18
2023-04-19
CADORET-MANIER ONAIZA
EVP, Chf GL Pdt Str & Oper Ofc
S - Sale
Common Stock
-2,582
$37.00
-95,534
1
$5.66B
2023-04-18
2023-04-19
BIRCHLER BRIAN
EVP, Corp and Development Ops
S - Sale
Common Stock
-672
$37.00
-24,864
1
$5.66B
2023-04-18
2023-04-19
BAROLDI JOSEPH
EVP, Chief Business Officer
S - Sale
Common Stock
-3,880
$37.00
-144K
1
$5.66B
2023-04-17
2023-04-19
BAROLDI JOSEPH
EVP, Chief Business Officer
M - Exercise
Common Stock
10,838
$0.00
1
$5.66B
2023-04-17
2023-04-19
BIRCHLER BRIAN
EVP, Corp and Development Ops
M - Exercise
Common Stock
1,875
$0.00
1
$5.66B
2023-04-17
2023-04-19
BAROLDI JOSEPH
EVP, Chief Business Officer
M - Exercise
Restricted Stock Unit
-10,838
$0.00
1
$5.66B
2023-04-17
2023-04-19
CADORET-MANIER ONAIZA
EVP, Chf GL Pdt Str & Oper Ofc
M - Exercise
Restricted Stock Unit
-5,667
$0.00
1
$5.66B
2023-04-17
2023-04-19
BIRCHLER BRIAN
EVP, Corp and Development Ops
M - Exercise
Restricted Stock Unit
-1,875
$0.00
1
$5.66B
2023-04-17
2023-04-19
CADORET-MANIER ONAIZA
EVP, Chf GL Pdt Str & Oper Ofc
M - Exercise
Common Stock
5,667
$0.00
1
$5.66B
2023-04-18
2023-04-17
CADORET-MANIER ONAIZA
EVP,Chf GL Pdt Str & Oper Ofc
S - Sale
-2,743
$38.00
-104K
1
$5.66B
2023-04-18
2023-04-17
BAROLDI JOSEPH
EVP, Chief Business Officer
S - Sale
-4,122
$38.00
-157K
1
$5.66B
2023-04-17
2023-04-17
BIRCHLER BRIAN
EVP, Corp and Development Ops
S - Sale
-713
$38.00
-27,094
1
$5.66B
2023-02-28
2023-03-02
O'NEIL PATRICK
EVP CLO & General Counsel
J - Other
Common Stock
301
$31.00
9,331
1
$5.66B
2023-02-28
2023-03-02
SWAYZE ERIC
EVP Research
J - Other
Common Stock
575
$31.00
17,825
1
$5.66B
2023-02-28
2023-03-02
HOUGEN ELIZABETH
EVP, Finance & CFO
J - Other
Common Stock
163
$31.00
5,053
1
$5.66B
2023-02-28
2023-03-02
GEARY RICHARD
EVP, Chief Development Officer
J - Other
Common Stock
575
$31.00
17,825
1
$5.66B
2023-02-28
2023-03-02
BENNETT FRANK
EVP, Chief Scientific Officer
J - Other
Common Stock
383
$31.00
11,873
1
$5.66B
2023-02-06
2023-02-07
GEARY RICHARD
EVP, Chief Development Officer
S - Sale
Common Stock
-1,920
$41.00
-78,720
1
$5.66B
2023-02-06
2023-02-07
CADORET-MANIER ONAIZA
EVP, Chf GL Pdt Str & Oper Ofc
S - Sale
Common Stock
-1,451
$41.00
-59,491
1
$5.66B
2023-02-06
2023-02-07
BENNETT FRANK
EVP, Chief Scientific Officer
S - Sale
Common Stock
-1,813
$41.00
-74,333
1
$5.66B